Subscribe To Our Free Newsletter |
Biocon Q2 Results: Profit zooms 168% YoY to Rs 126 crore; revenue jumps 49%
EBITDA for the quarter increased by 68% YoY to Rs 900 crore, representing an EBITDA margin of 25% versus 22% in the same period last year. The gross R&D spends grew 10% YoY to Rs 278 crore in Q2FY24.